- $6.15bn
- $6.87bn
- $4.32bn
- 94
- 46
- 93
- 92
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,940 | 3,728 | 3,541 | 3,615 | 4,321 |
Cost of Revenue | |||||
Gross Profit | 1,307 | 1,164 | 1,067 | 995 | 1,298 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,553 | 3,479 | 3,316 | 3,418 | 3,987 |
Operating Profit | 387 | 249 | 225 | 197 | 334 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 322 | 202 | 134 | 154 | 224 |
Provision for Income Taxes | |||||
Net Income After Taxes | 247 | 141 | 136 | 198 | 205 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 239 | 130 | 126 | 189 | 187 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 239 | 130 | 126 | 189 | 187 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.28 | 1.64 | 1.34 | 1.51 | 2.08 |
Dividends per Share |